Taysha Gene Therapies, Inc.
TSHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$89 | -$112 | -$166 | -$175 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13 | $8 | $18 | $18 |
| Change in WC | -$12 | -$18 | $19 | $29 |
| Other Non-Cash | $6 | $47 | $40 | $10 |
| Operating Cash Flow | -$81 | -$73 | -$88 | -$117 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$4 | -$25 | -$22 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$3 | -$0 | $0 |
| Investing Cash Flow | -$0 | -$7 | -$25 | -$22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$3 | $0 | $40 |
| Stock Issued | $77 | $141 | $53 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$1 | -$1 | -$1 |
| Financing Cash Flow | $77 | $136 | $52 | $39 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5 | $56 | -$61 | -$100 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $147 | $91 | $152 | $251 |
| End Cash | $142 | $147 | $91 | $152 |
| Free Cash Flow | -$82 | -$80 | -$113 | -$139 |